Status:
UNKNOWN
TAPB Combined With RSB Versus ESPB for Postoperative Analgesia After Laparoscopic Liver Resection
Lead Sponsor:
Zhangyi
Conditions:
Laparoscopic Hepatectomy
Nerve Block
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Postoperative pain after laparoscopic hepatectomy is composed of multiple factors, and the peak pain of postoperative pain mainly occurs within the first 24 hours, so it is particularly important to f...
Detailed Description
In a double-blind randomized controlled study, researchers randomized 60 patients undergoing laparoscopic hepatectomy to TAPB combined with RSB or ESPB, with both groups receiving additional standardi...
Eligibility Criteria
Inclusion
- ASA grades I-II;
- Age 18\~70 years old;
- BMI 19～28kg/m2;
- Patients undergoing elective laparoscopic partial liver resection;
Exclusion
- The nerve block cannot be performed, such as skin infection at the puncture site;
- Daily using the opioid analgesics or have a history of opioid abuse;
- Allergy or a history of drug allergy to any of the drugs used in the study;
- Patients have cognitive impairment, mental or neurological diseases, motor or sensory deficits;
- Coagulation disorders;
- Severe lung, heart, liver, or kidney dysfunction;
- Participating in other clinical trials within 3 months before being included in this study;
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06133725
Start Date
November 15 2023
End Date
December 1 2024
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, China, 430030